These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32741964)

  • 21. Risk factors for the onset and progression of Huntington disease.
    Chao TK; Hu J; Pringsheim T
    Neurotoxicology; 2017 Jul; 61():79-99. PubMed ID: 28111121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced-penetrance Huntington's disease-causing alleles with 39 CAG trinucleotide repeats could be a genetic factor of amyotrophic lateral sclerosis.
    Jih KY; Lai KL; Lin KP; Liao YC; Lee YC
    J Chin Med Assoc; 2023 Jan; 86(1):47-51. PubMed ID: 36599142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic data of Huntington disease in Moroccan patients.
    Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
    Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
    Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
    Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK; Goh JG
    J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis and natural history of Huntington disease.
    Pagan F; Torres-Yaghi Y; Altshuler M
    Handb Clin Neurol; 2017; 144():63-67. PubMed ID: 28947126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huntington disease reduced penetrance alleles occur at high frequency in the general population.
    Kay C; Collins JA; Miedzybrodzka Z; Madore SJ; Gordon ES; Gerry N; Davidson M; Slama RA; Hayden MR
    Neurology; 2016 Jul; 87(3):282-8. PubMed ID: 27335115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
    Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
    Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
    Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
    Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
    Nahhas F; Garbern J; Feely S; Feldman GL
    Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
    Cao GN; Bao XH; Lu HM; Zhang JJ; Ma YN; Gu WH; Xiong H; Qin J; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):163-7. PubMed ID: 21503105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.
    Lee JM; Galkina EI; Levantovsky RM; Fossale E; Anne Anderson M; Gillis T; Srinidhi Mysore J; Coser KR; Shioda T; Zhang B; Furia MD; Derry J; Kohane IS; Seong IS; Wheeler VC; Gusella JF; MacDonald ME
    Hum Mol Genet; 2013 Aug; 22(16):3227-38. PubMed ID: 23595883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal insults and neurodevelopmental disorders may impact Huntington's disease age of diagnosis.
    Barkhuizen M; Rodrigues FB; Anderson DG; Winkens B; ; Wild EJ; Kramer BW; Gavilanes AWD
    Parkinsonism Relat Disord; 2018 Oct; 55():55-60. PubMed ID: 29804730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of a (CAG)n repeat region in a sporadic case of HD.
    Bozza A; Malagù S; Calzolari E; Novelletto A; Pavoni M; del Senno L
    Acta Neurol Scand; 1995 Aug; 92(2):132-4. PubMed ID: 7484060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.
    McNicoll CF; Latourelle JC; MacDonald ME; Lew MF; Suchowersky O; Klein C; Golbe LI; Mark MH; Growdon JH; Wooten GF; Watts RL; Guttman M; Racette BA; Perlmutter JS; Ahmed A; Shill HA; Singer C; Saint-Hilaire MH; Massood T; Huskey KW; DeStefano AL; Gillis T; Mysore J; Goldwurm S; Pezzoli G; Baker KB; Itin I; Litvan I; Nicholson G; Corbett A; Nance M; Drasby E; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Al-Hinti J; Moller AT; Ostergaard K; Sherman SJ; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    Mov Disord; 2008 Aug; 23(11):1596-601. PubMed ID: 18649400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-step scalable-throughput molecular screening for Huntington disease.
    Teo CR; Wang W; Yang Law H; Lee CG; Chong SS
    Clin Chem; 2008 Jun; 54(6):964-72. PubMed ID: 18403567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.